Revolution Beauty Group plc (Revolution Beauty) announced that it acquired the entire issued share capital of Medichem Manufacturing Ltd (Medichem) for £23 million.
Revolution Beauty is an AIM-quoted, global mass beauty and personal care business. The company operates a multi-brand and multi-category strategy to sell its products through e-commerce operations and, both physical and digital, retailers with wholesale relationships.
This is Revolution Beauty’s first acquisition and provides the group with its own manufacturing business.
Medichem is a long-standing supplier of haircare and skincare products to Revolution Beauty, manufacturing all products from its UK facility. Medichem's operations include an R&D laboratory, bulk manufacturing, warehousing and distribution, and it employs more than 170 people.
Crowe acted as the financial and tax due diligence advisors on the transaction. Our Transaction Services team was led by Peter Varley, George Lawford and Conor Monaghan.
"Crowe delivered a good due diligence report on time and with the salient points for us to focus our attention on. Their support with the negotiations was particularly helpful and enabled us to close the deal successfully."
Derek Zissman, Deputy Chairman and Senior Independent Non-Executive Director, Revolution Beauty